| Target Price | $255.00 |
| Price | $246.45 |
| Potential |
3.47%
register free of charge
|
| Number of Estimates | 18 |
|
18 Analysts have issued a price target Quest Diagnostics 2027 .
The average Quest Diagnostics target price is $255.00.
This is
3.47%
register free of charge
$278.25
12.90%
register free of charge
$210.42
14.62%
register free of charge
|
|
| A rating was issued by 23 analysts: 13 Analysts recommend Quest Diagnostics to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2027 of
3.47%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 11.04 | 12.12 |
| 11.78% | 9.81% | |
| EBITDA Margin | 16.36% | 19.89% |
| 5.20% | 21.60% | |
| Net Margin | 8.95% | 10.26% |
| 2.06% | 14.59% |
20 Analysts have issued a sales forecast Quest Diagnostics 2026 . The average Quest Diagnostics sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an Quest Diagnostics EBITDA forecast 2026. The average Quest Diagnostics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Quest Diagnostics Analysts have issued a net profit forecast 2026. The average Quest Diagnostics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 8.74 | 11.30 |
| 14.10% | 29.29% | |
| P/E | 21.81 | |
| EV/Sales | 2.66 |
21 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics EPS is
This results in the following potential growth metrics and future valuations:
Quest Diagnostics...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 08 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Jul 24 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 08 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jul 24 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Jul 24 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


